» Articles » PMID: 36192553

How COVID-19 Shaped Mental Health: from Infection to Pandemic Effects

Overview
Journal Nat Med
Date 2022 Oct 3
PMID 36192553
Authors
Affiliations
Soon will be listed here.
Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic has threatened global mental health, both indirectly via disruptive societal changes and directly via neuropsychiatric sequelae after SARS-CoV-2 infection. Despite a small increase in self-reported mental health problems, this has (so far) not translated into objectively measurable increased rates of mental disorders, self-harm or suicide rates at the population level. This could suggest effective resilience and adaptation, but there is substantial heterogeneity among subgroups, and time-lag effects may also exist. With regard to COVID-19 itself, both acute and post-acute neuropsychiatric sequelae have become apparent, with high prevalence of fatigue, cognitive impairments and anxiety and depressive symptoms, even months after infection. To understand how COVID-19 continues to shape mental health in the longer term, fine-grained, well-controlled longitudinal data at the (neuro)biological, individual and societal levels remain essential. For future pandemics, policymakers and clinicians should prioritize mental health from the outset to identify and protect those at risk and promote long-term resilience.

Citing Articles

Incidence and prevalence of dysthymia among young adults in China, 1990-2021, with forecasts to 2046: an age-period-cohort analysis of the Global Burden of Disease Study 2021.

Wu J, Deng Y, Tong K, Sun Z BMC Psychiatry. 2025; 25(1):238.

PMID: 40082857 PMC: 11905626. DOI: 10.1186/s12888-025-06680-z.


Symptoms of Mental Health Conditions and Their Predictors Among U.S. Adults During the First Year of the COVID-19 Pandemic.

Boyle J, Dayton J, ZuWallack R, Iachan R, Krugipudi D, Blanco C Healthcare (Basel). 2025; 13(5).

PMID: 40077082 PMC: 11898436. DOI: 10.3390/healthcare13050519.


Psychiatric and neuropsychiatric sequelae of COVID-19 within 2 years: a multinational cohort study.

Chai Y, Lam I, Man K, Hayes J, Wan E, Li X BMC Med. 2025; 23(1):144.

PMID: 40055683 PMC: 11887073. DOI: 10.1186/s12916-025-03952-z.


Impact of coronavirus disease 2019 pandemic on the trends of care-seeking behavior for ocular diseases: a systematic review and meta-analysis.

Hirosawa K, Inomata T, Nagino K, Sung J, Midorikawa-Inomata A, Inagaki K Sci Rep. 2025; 15(1):7800.

PMID: 40050389 PMC: 11885659. DOI: 10.1038/s41598-025-92279-z.


Specialized mental healthcare use for common mental disorders and prescription of antidepressants before and during the COVID-19 pandemic among working-age refugees and Swedish-born individuals - a nationwide register-based study.

Atarodi V, Mittendorfer-Rutz E, Morillo-Cuadrado D, Mediavilla R, Felez-Nobrega M, Monistrol-Mula A BMC Public Health. 2025; 25(1):840.

PMID: 40033262 PMC: 11874784. DOI: 10.1186/s12889-025-22028-4.


References
1.
Nalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stevens J . Post-acute COVID-19 syndrome. Nat Med. 2021; 27(4):601-615. PMC: 8893149. DOI: 10.1038/s41591-021-01283-z. View

2.
Penninx B, Pine D, Holmes E, Reif A . Anxiety disorders. Lancet. 2021; 397(10277):914-927. PMC: 9248771. DOI: 10.1016/S0140-6736(21)00359-7. View

3.
Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P . Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022; 399(10328):957-1022. DOI: 10.1016/S0140-6736(21)02141-3. View

4.
Dragioti E, Li H, Tsitsas G, Lee K, Choi J, Kim J . A large-scale meta-analytic atlas of mental health problems prevalence during the COVID-19 early pandemic. J Med Virol. 2021; 94(5):1935-1949. PMC: 9015528. DOI: 10.1002/jmv.27549. View

5.
Zhang S, Batra K, Xu W, Liu T, Dong R, Yin A . Mental disorder symptoms during the COVID-19 pandemic in Latin America - a systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2022; 31:e23. PMC: 9069590. DOI: 10.1017/S2045796021000767. View